12/17/2025
As 2025 draws to a close, we owe a heartfelt thank‑you to the leaders and organizations that stood with us all year, our Corporate Advisory Council members:
Amgen
AstraZeneca
Bayer Health Care
Boehringer Ingelheim/Lilly Alliance
Cytokinetics
Genentech
Edwards Lifesciences
Johnson & Johnson Health Care
BMS/Pfizer Alliance
Bristol Myers Squibb
Lilly
Medtronic
Merck
Novartis
Novo Nordisk
Your partnership, passion, and support have helped us expand outreach, amplify women’s voices in heart health, and bring resources to communities that need them most.
Here is some of what we have accomplished together this year:
* 2025 WomenHeart Summit and the Heart Health Is Women’s Health Forum during Heart Month, presented in partnership with HealthyWomen
* “Could It Be My Heart? Valve Disease in Women” webinar, hosted with Heart Valve Voice U.S.
* Launch of a new Cardio-Renal-Metabolic Education and Support Program
* Year 1 of Treat Me Right: Improving Heart Care for Women to advance awareness and education about misdiagnosis and evidence-based care for women
* Debut of the ENACT Clinical Trials website, developed with Mended Hearts
* Release of a new ATTR-CM training module and companion webinar
* Educational webinar on Gene Therapy Clinical Trials
* Investment in the Quorum advocacy platform, establishing a new Action Center for grassroots mobilization
* Virtual and In-Person Science & Leadership Champion Training to create new classes of Champions working in communities across the nation
* A Women & Heart Disease film and article produced by BBC StoryWorks Commercial Production as part of the World Heart Federation’s Beats of Change series
* Educational screening event in Miami, FL for Making of a Heart Attack, featuring WomenHeart Champions
* Heart disease screening and community activation at the African American Cultural Festival in Raleigh, NC and the St. Louis Cardinals’ last game of the season.
* Expansion of the WomenHeart team with two new staff members
Here’s to 2026, stronger together. 💝